期刊文献+

乳腺浸润性小叶癌的临床病理特征及保乳切缘阳性的危险因素分析 被引量:3

Invasive Lobular Carcinoma of the Breast-Conserving Clinicopathological Features and Risk Factors Analysis for Positive Margin
下载PDF
导出
摘要 目的探讨乳腺浸润性小叶癌的临床病理特征及保乳切缘阳性的危险因素分析。方法回顾我院2000年至2012年浸润性小叶癌病例资料,描述浸润性小叶癌临床病理特征,分析影响保乳切缘的临床病理因素。结果我院浸润性小叶癌手术患者78例,其中行保乳手术患者20例,一次手术保乳成功率为60%。单因素分析切检(P=0.009),超声/钼靶提示结构紊乱(P=0.009),超声/钼靶提示多中心或多灶性(P=0.006),术前核磁检查提示多中心或多灶性(P=0.002)与阳性切缘显著相关。Logistic回归表明术前核磁检查结果为影响保乳切缘的主要危险因素(P=0.025)。结论浸润性小叶癌可选择保乳的手术方式,术前核磁检查提示多中心或多灶性的患者保乳切缘阳性风险较大。保乳术前核磁检查应尤为重视。 Objective Discussion invasive lobular carcinoma clinicopathological features and conserving positive margin analysis of risk factors. Methods Clinicop athologic features of ILC patients between 2000 and 2012 were retrospectively reviewed to determine if specific clinical and pathologic factors influenced the margins status after breast conserving surgery. Results 78 cases of ILC were reviewed, 20 patients received breast conserving surgery(BCS) as their initial procedure. BCS was successful in 60% patients who received negative margin after 1 surgical procedure. An ultrasonographic/ mammography diagnosis of architectural distortion(P= 0.009), an ultrasonographic or mammography diagnosis of mulifocality and multicentricity lesions(P= 0.002), excisional biopsy(P= 0.009), mulifocality and multicentricity findings by MRI(P= 0.002) were significantly associated with close of positive margins on univariate analysis. Multivariable logistic regression analysis, only MRI diagnosis retained statistical significance(P= 0.025). Conclusion ILC was not a contradiction of breast conserving surgery. MRI diagnosis is a critical predictive factor of margin status after BCS. With appropriate patient selection, most patients can undergo successful BCS. Based on the currently available data, it is strongly recommended that preoperative MR imaging be conducted in all patients with ILC prior to therapy.
出处 《中国医药指南》 2014年第18期58-60,共3页 Guide of China Medicine
关键词 乳腺浸润性小叶癌 病理特征 保乳 危险因素 Invasive lobular carcinoma Pathology Breast-conserving Risk factors
  • 相关文献

参考文献14

  • 1Cao AY,Huang L,Wu J,et al.Tumor characteristics and the clinicaloutcome of invasive lobular carcinoma compared to infiltratingductal carcinoma in a Chinese population[J].World J SurgOncol,2012,10:152.
  • 2李崖青,郭晓静,刘芳芳,傅西林,付丽.乳腺浸润性小叶癌的研究进展[J].中国肿瘤临床,2012,29(3):170-173. 被引量:15
  • 3Galimberti V,Maisonneuve P,Rotmensz N,et al.Influence of marginstatus on outcomes in lobular carcinoma:experience of the EuropeanInstitute of Oncology[J].Ann Surg,2011,253(3):580-584.
  • 4Sikora MJ,Jankowitz RC,Dabbs DJ,et al.Invasive lobularcarcinoma of the breast:Patient response to systemic endocrinetherapy and hormone response in model systems[J].Steroids,2013,78(6):568-575.
  • 5张奇兵,杨明,张鹏,刘涛,范志民.乳腺浸润性小叶癌临床病理特点[J].中国老年学杂志,2011,31(17):3246-3248. 被引量:6
  • 6Litiere S,Werutsky G,Fentiman IS,et al.Breast conservingtherapy versus mastectomy for stage I-II breast cancer:20 yearfollow-up of the EORTC 10801 phase 3 randomised trial[J].Lancet 0ncol,2012,13(4):412-419.
  • 7Kapoor NS,Eaton A,King TA,et al.Should Breast DensityInfluence Patient Selection for Breast-Conserving Surgery? [J].Ann Surg Oncol,2013,20(2):600-606.
  • 8Fodor J,Sulyok Z,Polgar C,et al.Breast-conserving treatmentfor early invasive lobular breast cancer:15 years results[J].MagySeb,2001,54(4):209-214.
  • 9Shah C,Wilkinson JB,Shaitelman S,et al.Clinical outcomes usingaccelerated partial breast irradiation in patients with invasivelobular carcinoma[J].Int J Radiat Oncol Biol Phys,2011,81(4):e547-551.
  • 10Dillon MF,Hill AD,Fleming FJ,et al.Identifying patients at riskof compromised margins following breast conservation forlobular carcinoma[J].Am J Surg,2006,191(2):201-205.

二级参考文献37

  • 1Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P. World Health Organization classification of tumos. Pathology and genetics of tumors of the breast and female genital organs[M]. Lyon,France: IARC Press; 2003:23-6.
  • 2Arpino G, Bardou V J, Clark GM,et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome[ J]. Breast Cancer Res,2004 ;6 (3) : 149-56.
  • 3Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer[J]. Radiology,2004 ; 233 ( 3 ) :830-49.
  • 4Watermann DO, Tempfer C, Hetler LA, et al. Uhrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer[J]. Ultrasound Med Biol,2005 ;31 ( 2 ) : 167-74.
  • 5Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma [J]. J Clin Ultrasound, 2004 ; 32 (7) :323-32.
  • 6Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast : histopathologic correlation [J]. Am J Roentgenol 2002 ; 178 ( 5 ) : 1227-32.
  • 7Tubiana-Hulin M, Stevens D, Lasry S, et al. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution[J]. Ann Oncol,2006 ; 17 ( 8 ) : 1228-33.
  • 8Coradini D, Pellizzaro C, Veneroni S, et al. Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence[J]. Br J Cancer,2002 ;87 (10) :1105-11.
  • 9International Breast Cancer Study Group, Colleoni M, Gelber S, et al. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93[J]. J Clin Oncol,2006 ;24(9) : 1332-41.
  • 10Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER 2-positive breast cancer [J]. N Engl J Med ,2005 ;353 ( 16 ) : 1659-72.

共引文献18

同被引文献17

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部